TBP:CC News and Press, Tetra Bio-Pharma Inc. From 08/11/22

Tetra Bio-Pharma Inc. Secures $6,000,000 Financing from Alpha Blue Ocean Canada NewsWire OTTAWA, ON , Aug. 11, 2022 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoi...

Tetra Bio-Pharma Announces Positive Preclinical Results of ARDS-003, a Novel Therapeutic for Sepsis and Viral Infections Canada NewsWire ARDS-003 is a novel therapeutic for acute systemic inflammation and prevention of acute respiratory distress syndrome (ARDS). ...

Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug Canada NewsWire Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to s...

Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update Canada NewsWire OTTAWA, ON , June 6, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA: JAM1 ), a leader ...

Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting Canada NewsWire OTTAWA, ON , May 31, 2022 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a lead...

Tetra Bio-Pharma Appoints Chief Financial Officer Canada NewsWire OTTAWA, ON , May 30, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1) a leader in cannabinoid-derived drug discovery and development i...

Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD Canada NewsWire Novel proprietary cannabidiol (CBD) therapeutic has been classified as an orphan medicinal product for the indication of epidermolysis bullosa (EB). ...

Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate Canada NewsWire OTTAWA, ON , May 17, 2022 /CNW/ - Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery...

Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology Canada NewsWire Panag Pharma Inc (Panag), a subsidiary of Tetra Bio-Pharma, will collect royalties on sales on products produced with the technology True North has licensed from ...

Tetra Bio-Pharma and Cannvalate Enter Into Partnership Canada NewsWire Cannvalate to invest CAD$7.5M in Tetra. Cannvalate to launch and manage QIXLEEF™ and CAUMZ™ clinical trials in Australia . The Company to benefit from a 43.5% tax credi...